Liu H - Search Results

1

Switch receptor T3/28 improves long-term persistence and antitumor efficacy of CAR-T cells.

Zhao S, Wang C, Lu P, Lou Y, Liu H, Wang T, Yang S, Bao Z, Han L, Liang X, Ma C, Gao L. Zhao S, et al. Among authors: liu h. J Immunother Cancer. 2021 Nov;9(12):e003176. doi: 10.1136/jitc-2021-003176. J Immunother Cancer. 2021. PMID: 34853180 Free PMC article.

2

High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma.

Tang Y, Yin H, Zhao X, Jin D, Liang Y, Xiong T, Li L, Tang W, Zhang J, Liu M, Yu Z, Liu H, Zang S, Huang Z. Tang Y, et al. Among authors: liu h, liu m. J Exp Clin Cancer Res. 2022 Jan 3;41(1):2. doi: 10.1186/s13046-021-02214-z. J Exp Clin Cancer Res. 2022. PMID: 34980210 Free PMC article.

3

TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.

Gao C, Yao H, Liu H, Feng Y, Yang Z. Gao C, et al. Among authors: liu h. BMC Cancer. 2019 Mar 15;19(1):237. doi: 10.1186/s12885-019-5417-7. BMC Cancer. 2019. PMID: 30876464 Free PMC article.

4

miR‑140‑5p inhibits the proliferation of multiple myeloma cells by targeting VEGFA.

Liu M, Liu H, Zhou J, Yu Z. Liu M, et al. Among authors: liu h. Mol Med Rep. 2021 Jan;23(1):53. doi: 10.3892/mmr.2020.11691. Epub 2020 Nov 17. Mol Med Rep. 2021. PMID: 33200797 Free PMC article.

5

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma.

Hu Y, Liu H, Fang C, Li C, Xhyliu F, Dysert H, Bodo J, Habermehl G, Russell BE, Li W, Chappell M, Jiang X, Ondrejka SL, Hsi ED, Maciejewski JP, Yi Q, Anderson KC, Munshi NC, Ao G, Valent JN, Lin J, Zhao J. Hu Y, et al. Among authors: liu h. Cancer Res. 2020 May 15;80(10):2031-2044. doi: 10.1158/0008-5472.CAN-19-1077. Epub 2020 Mar 19. Cancer Res. 2020. PMID: 32193289 Free PMC article.

6

Downregulated miR‑130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin.

Liu H, Liu M, Zhang J, Liang Y. Liu H, et al. Among authors: liu m. Mol Med Rep. 2020 Oct;22(4):2810-2816. doi: 10.3892/mmr.2020.11375. Epub 2020 Jul 28. Mol Med Rep. 2020. PMID: 32945422 Free PMC article.

7

The Long Noncoding RNA, Growth Arrest-Specific 5, Suppresses Gastric Cancer by Downregulating miR-21 Expression.

Li W, Peng X, Wang Z, Zhang H, Huang H, Liu H, Cai L. Li W, et al. Among authors: liu h. Pharmacology. 2020;105(7-8):434-444. doi: 10.1159/000504674. Epub 2020 Jan 7. Pharmacology. 2020. Retraction in: Pharmacology. 2024 Nov 5:1. doi: 10.1159/000542299. PMID: 31910411 Free article. Retracted.

8

CFTR inhibits the invasion and growth of esophageal cancer cells by inhibiting the expression of NF-κB.

Li W, Wang C, Peng X, Zhang H, Huang H, Liu H. Li W, et al. Among authors: liu h. Cell Biol Int. 2018 Dec;42(12):1680-1687. doi: 10.1002/cbin.11069. Cell Biol Int. 2018. PMID: 30358020

9

Silencing of Peroxiredoxin 1 Inhibits the Proliferation of Esophageal Cancer Cells and Promotes Apoptosis by Inhibiting the Activity of the PI3K/AKT Pathway.

Song Y, Liu H, Cui C, Peng X, Wang C, Tian X, Li W. Song Y, et al. Among authors: liu h. Cancer Manag Res. 2019 Dec 30;11:10883-10890. doi: 10.2147/CMAR.S235317. eCollection 2019. Cancer Manag Res. 2019. PMID: 31920397 Free PMC article.

10

Does higher serum 25-hydroxyvitamin D levels will harm bone mineral density?: a cross-sectional study.

Xu B, Li Q, Luo B, Liu H. Xu B, et al. Among authors: liu h. BMC Endocr Disord. 2024 Nov 18;24(1):250. doi: 10.1186/s12902-024-01760-9. BMC Endocr Disord. 2024. PMID: 39558288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95,307 results

Search Page

Filters